Therapeutic remodeling of the ceramide backbone prevents kidney injury

神经酰胺骨架的治疗性重塑可预防肾损伤

阅读:12
作者:Rebekah J Nicholson ,Luis Cedeño-Rosario ,J Alan Maschek ,Trevor Lonergan ,Jonathan G Van Vranken ,Angela R S Kruse ,Chris J Stubben ,Liping Wang ,Deborah Stuart ,Queren A Alcantara ,Monica P Revelo ,Kate Rutter ,Mayette Pahulu ,Jacob Taloa ,Xuanchen Wu ,Juwan Kim ,Juna Kim ,Isaac Hall ,Amanda J Clark ,Samir Parikh ,Jeffrey Spraggins ,Donna Romero ,Jeremy T Blitzer ,Steven P Gygi ,Jared Rutter ,William L Holland ,Nirupama Ramkumar ,Scott A Summers

Abstract

Perturbation of proximal tubule (PT) lipid metabolism fuels the pathological features of acute kidney injury (AKI). We found that AKI induced biosynthesis of lipotoxic ceramides within PTs in humans and mice and that urine ceramides predicted disease severity in children and adults. Mechanistic studies in primary PTs, which included a thermal proteomic profiling screen for ceramide effectors, revealed that ceramides altered assembly of the mitochondrial contact site and cristae-organizing system (MICOS) and respiratory supercomplexes, leading to acute disruption of cristae architecture, mitochondrial morphology, and respiration. These ceramide actions were dependent on the presence of the 4,5-trans double bond inserted by dihydroceramide desaturase 1 (DES1). Genetically ablating DES1 preserved mitochondrial integrity and prevented kidney injury in mice following bilateral ischemia reperfusion. Moreover, novel DES1 inhibitors that are attractive clinical drug candidates phenocopied the DES1 knockouts. These studies describe a new, therapeutically tractable mechanism underlying PT mitochondrial damage in AKI. Keywords: ETC; MICOS; acute kidney injury; ceramides; cristae; lipid metabolism; lipidomics; metabolism; mitochondria; proximal tubule; sphingolipids.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。